COVID-19 Convalescent Plasma Fails to Halt Disease Progression
J&J COVID-19 Vaccine Booster Elicits Strong Antibody Responses
Novartis Cancer Treatment Fails in Phase 3 Clinical Trial
Role of Digital Therapeutics in Chronic Disease Management
FDA Accept Johnson & Johnson’s Expanded Indication for Xarelto
FDA Accepts Biologics License Application for BMS aGvHD Therapy
Pfizer Enters Acquisition Deal for Immuno-Therapeutics Pipeline
AstraZeneca’s COVID-19 Antibody 77% Effective in Phase 3 Trial
FDA Grants Accelerated Approval to GSK’s dMMR Antibody Drug
CureVac’s Second COVID-19 Vaccine Elicits Improved Immune Response
Novartis’ Diabetic Macular Edema Drug Successful in 2 Trials
Pfizer-BioNTech COVID-19 Vaccine Gets Full FDA Approval
GoodRx, Boehringer Increase Affordable Drug Access for Patients
New CEO to Take Over for Gorsky at Johnson & Johnson
FDA Approves Abbott’s Atrial Fibrillation Device to Prevent Stroke
Moderna Doses First Patient in Study of mRNA Therapeutic for MMA
FDA Authorizes Thermo Fisher’s PCR-Based COVID-19 Test Kits
FDA Approves New Indication for Chronic Disease Treatment
UPMC Expands Access to Monoclonal COVID-19 Antibody Treatments
WHO Launches Next Trial Phase to Test COVID-19 Drugs in Patients
NCQA Program Supports Best Practices in Specialty Pharmacy
FDA OKs 3rd COVID-19 Vaccine Dose for the Immunocompromised
Most Important FDA Novel Drug Approvals of 2021, So Far
Novavax’s COVID-19 Vaccine Booster Neutralizing Antibody Levels
FDA Accepts Merck’s Keytruda Application for Endometrial Carcinoma
Bayer Enters Pharma Acquisition Deal for Undruggable Targets
Kite, Appia Bio to Research Allogeneic Cell Therapies for Cancer
Moderna Doses First Patient in Study of Autoimmune mRNA Candidate
FDA Grants Fast Track to Moderna’s mRNA RSV Vaccine for Adults
FDA Broadens Authorization for Eli Lilly’s COVID-19 Treatment
51% of Retail Pharmacy Customers Used Wellness Services in 2020-21
FDA Approves GSK’s Antibody for Chronic Disease Management
Sanofi, Translate Enter Pharma Acquisition Deal for mRNA Vaccines
FDA Expands Authorization of Regeneron’s COVID-19 Antibody Cocktail
Roche Gets FDA Priority Review for Non-Small Cell Lung Cancer Drug
Eli Lilly, Kumquat to Discover Drug Candidates for Tumors
Amgen Enters Pharma Acquisition Deal to Develop New Biologics
AstraZeneca, Regeneron to Develop Drug Candidates to Treat Obesity
UIC Awarded $6M to Test COVID-19 Drug Candidate For Lung Damage
Biogen’s Alzheimer’s Disease Drug Safe, Effective in Trial